^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Rectal Cancer |
| Drug: | 5-fluorouracil (Thymidylate synthase inhibitor) + leucovorin calcium (Folate analog) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Rectal cancer: CONTINUUM OF CARE - SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE...Patient not appropriate for intensive therapy...5-FU ± leucovorin ± bevacizumab
